{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:57:18Z","timestamp":1781531838883,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00742-w","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:44:45Z","timestamp":1767015885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In silico discovery and experimental validation of natural derivatives as inhibitor of phosphoinositide Kinase, PIKfyve"],"prefix":"10.1007","volume":"40","author":[{"given":"Vipul","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma Khatoon","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvnesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anugya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"742_CR1","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.jbior.2023.101001","volume":"91","author":"SR Lourdes","year":"2024","unstructured":"Lourdes SR, Gurung R, Giri S et al (2024) A new role for phosphoinositides in regulating mitochondrial dynamics. Adv Biol Regul 91:101001. https:\/\/doi.org\/10.1016\/j.jbior.2023.101001","journal-title":"Adv Biol Regul"},{"key":"742_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2024.2437513","volume":"0","author":"BN Wadje","year":"2024","unstructured":"Wadje BN, Somarowthu T, Thakur S et al (2024) Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve. J Biomol Struct Dyn 0:1\u201316. https:\/\/doi.org\/10.1080\/07391102.2024.2437513","journal-title":"J Biomol Struct Dyn"},{"key":"742_CR3","doi-asserted-by":"publisher","first-page":"971453","DOI":"10.1155\/2015\/971453","volume":"2015","author":"RK Upadhyay","year":"2015","unstructured":"Upadhyay RK (2015) Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids 2015:971453 https:\/\/doi.org\/10.1155\/2015\/971453","journal-title":"J Lipids"},{"key":"742_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/acs.jmedchem.1c00302","volume":"65","author":"J Garc\u00eda-C\u00e1rceles","year":"2022","unstructured":"Garc\u00eda-C\u00e1rceles J, Caballero E, Gil C, Mart\u00ednez A (2022) Kinase inhibitors as underexplored antiviral agents. J Med Chem 65:935\u2013954. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00302","journal-title":"J Med Chem"},{"key":"742_CR5","doi-asserted-by":"publisher","first-page":"102187","DOI":"10.1016\/j.jbc.2022.102187","volume":"298","author":"GT Saffi","year":"2022","unstructured":"Saffi GT, Wang CA, Mangialardi EM et al (2022) Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity. J Biol Chem 298:102187. https:\/\/doi.org\/10.1016\/j.jbc.2022.102187","journal-title":"J Biol Chem"},{"key":"742_CR6","doi-asserted-by":"publisher","first-page":"102086","DOI":"10.1016\/j.ceb.2022.102086","volume":"76","author":"P Rivero-R\u00edos","year":"2022","unstructured":"Rivero-R\u00edos P, Weisman LS (2022) Roles of PIKfyve in multiple cellular pathways. Curr Opin Cell Biol 76:102086. https:\/\/doi.org\/10.1016\/j.ceb.2022.102086","journal-title":"Curr Opin Cell Biol"},{"key":"742_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1074\/jbc.R117.000629","volume":"293","author":"A Wallroth","year":"2018","unstructured":"Wallroth A, Haucke V (2018) Phosphoinositide conversion in endocytosis and the endolysosomal system. J Biol Chem 293:1526\u20131535. https:\/\/doi.org\/10.1074\/jbc.R117.000629","journal-title":"J Biol Chem"},{"key":"742_CR8","doi-asserted-by":"publisher","first-page":"35794","DOI":"10.1074\/jbc.M109.037515","volume":"284","author":"OC Ikonomov","year":"2009","unstructured":"Ikonomov OC, Sbrissa D, Fenner H, Shisheva A (2009) PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis. J Biol Chem 284:35794\u201335806. https:\/\/doi.org\/10.1074\/jbc.M109.037515","journal-title":"J Biol Chem"},{"key":"742_CR9","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1074\/jbc.M110194200","volume":"277","author":"D Sbrissa","year":"2002","unstructured":"Sbrissa D, Ikonomov OC, Shisheva A (2002) Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve endomembrane localization. J Biol Chem 277:6073\u20136079. https:\/\/doi.org\/10.1074\/jbc.M110194200","journal-title":"J Biol Chem"},{"key":"742_CR10","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/acsmedchemlett.3c00212","volume":"14","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Bourne PE (2023) How ligands interact with the kinase hinge. ACS Med Chem Lett 14:1503\u20131508. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00212","journal-title":"ACS Med Chem Lett"},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1021\/acs.jmedchem.4c02531","volume":"68","author":"SM Min","year":"2025","unstructured":"Min SM, Bashore FM, Smith JL et al (2025) Development of a Second-Generation, in vivo chemical probe for PIKfyve. J Med Chem 68:3282\u20133308. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02531","journal-title":"J Med Chem"},{"key":"742_CR12","doi-asserted-by":"crossref","unstructured":"Uwada J, Nakazawa H, Kiyoi T et al (2024) PIKFYVE inhibition induces endosome- and lysosome-derived vacuole enlargement via ammonium accumulation","DOI":"10.1101\/2024.04.19.590364"},{"key":"742_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/sj.embor.7401155","volume":"9","author":"HBJ Jefferies","year":"2008","unstructured":"Jefferies HBJ, Cooke FT, Jat P et al (2008) A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep 9:164\u2013170. https:\/\/doi.org\/10.1038\/sj.embor.7401155","journal-title":"EMBO Rep"},{"key":"742_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s43018-021-00237-1","volume":"2","author":"Y Qiao","year":"2021","unstructured":"Qiao Y, Choi JE, Tien JC et al (2021) Autophagy Inhibition by targeting PIKfyve potentiates response to immune checkpoint Blockade in prostate cancer. Nat Cancer 2:978\u2013993. https:\/\/doi.org\/10.1038\/s43018-021-00237-1","journal-title":"Nat Cancer"},{"key":"742_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/FJC.0000000000001243","volume":"79","author":"M Gu","year":"2022","unstructured":"Gu M, Wang Z, Feng F et al (2022) Inhibition of PIKfyve ameliorates the proliferation and migration of vascular smooth muscle cells and vascular intima hyperplasia by reducing mTORC1 activity. J Cardiovasc Pharmacol 79:739\u2013748. https:\/\/doi.org\/10.1097\/FJC.0000000000001243","journal-title":"J Cardiovasc Pharmacol"},{"key":"742_CR16","doi-asserted-by":"publisher","first-page":"20803","DOI":"10.1073\/pnas.2007837117","volume":"117","author":"Y-L Kang","year":"2020","unstructured":"Kang Y-L, Chou Y-Y, Rothlauf PW et al (2020) Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc Natl Acad Sci U S A 117:20803\u201320813. https:\/\/doi.org\/10.1073\/pnas.2007837117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"742_CR17","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3892\/or.2018.6928","volume":"41","author":"JZ Hou","year":"2019","unstructured":"Hou JZ, Xi ZQ, Niu J et al (2019) Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy. Oncol Rep 41:1971\u20131979. https:\/\/doi.org\/10.3892\/or.2018.6928","journal-title":"Oncol Rep"},{"key":"742_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/d41573-021-00158-9","volume":"20","author":"P-T Huang","year":"2021","unstructured":"Huang P-T, Einav S, Asquith CRM (2021) PIKfyve: a lipid kinase target for COVID-19, cancer and neurodegenerative disorders. Nat Rev Drug Discov 20:730","journal-title":"Nat Rev Drug Discov"},{"key":"742_CR19","doi-asserted-by":"publisher","first-page":"12860","DOI":"10.1021\/acs.jmedchem.2c00697","volume":"65","author":"DH Drewry","year":"2022","unstructured":"Drewry DH, Potjewyd FM, Bayati A et al (2022) Identification and utilization of a chemical probe to interrogate the roles of PIKfyve in the lifecycle of \u03b2-Coronaviruses. J Med Chem 65:12860\u201312882. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00697","journal-title":"J Med Chem"},{"key":"742_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s44442-025-00012-2","volume":"29","author":"J Xing","year":"2025","unstructured":"Xing J, Yao C, Xu Y et al (2025) Synthesis, characterization, and antiviral activity of 1,3,5-triazine derivatives as potential PIKfyve inhibitor. J Saudi Chem Soc 29:15. https:\/\/doi.org\/10.1007\/s44442-025-00012-2","journal-title":"J Saudi Chem Soc"},{"key":"742_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","volume":"129","author":"S Gayle","year":"2017","unstructured":"Gayle S, Landrette S, Beeharry N et al (2017) Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood 129:1768\u20131778. https:\/\/doi.org\/10.1182\/blood-2016-09-736892","journal-title":"Blood"},{"key":"742_CR22","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.chembiol.2013.05.010","volume":"20","author":"X Cai","year":"2013","unstructured":"Cai X, Xu Y, Cheung AK et al (2013) PIKfyve, a class III PI kinase, is the target of the small molecular IL-12\/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. Chem Biol 20:912\u2013921. https:\/\/doi.org\/10.1016\/j.chembiol.2013.05.010","journal-title":"Chem Biol"},{"key":"742_CR23","doi-asserted-by":"publisher","first-page":"e60152","DOI":"10.1371\/journal.pone.0060152","volume":"8","author":"S Martin","year":"2013","unstructured":"Martin S, Harper C, May L et al (2013) Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to Apoptosis-Independent neuronal cell death. PLoS ONE 8:e60152. https:\/\/doi.org\/10.1371\/journal.pone.0060152","journal-title":"PLoS ONE"},{"key":"742_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","volume":"22","author":"JE Burke","year":"2023","unstructured":"Burke JE, Triscott J, Emerling BM, Hammond GRV (2023) Beyond PI3Ks: targeting phosphoinositide kinases in disease. Nat Rev Drug Discov 22:357\u2013386. https:\/\/doi.org\/10.1038\/s41573-022-00582-5","journal-title":"Nat Rev Drug Discov"},{"key":"742_CR25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/15548627.2019.1586257","volume":"15","author":"G Sharma","year":"2019","unstructured":"Sharma G, Guardia CM, Roy A et al (2019) A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis. Autophagy 15:1694\u20131718. https:\/\/doi.org\/10.1080\/15548627.2019.1586257","journal-title":"Autophagy"},{"key":"742_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/acs.jmedchem.3c01039","volume":"67","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu S, Wei Y et al (2024) Discovery of potent and selective phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) inhibitors as methuosis inducers. J Med Chem 67:165\u2013179. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01039","journal-title":"J Med Chem"},{"key":"742_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","volume":"52","author":"E Davison","year":"2019","unstructured":"Davison E, Brimble M (2019) Natural product derived privileged scaffolds in drug discovery. Curr Opin Chem Biol 52:1\u20138. https:\/\/doi.org\/10.1016\/j.cbpa.2018.12.007","journal-title":"Curr Opin Chem Biol"},{"key":"742_CR28","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"GM Cragg","year":"2013","unstructured":"Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830:3670\u20133695. https:\/\/doi.org\/10.1016\/j.bbagen.2013.02.008","journal-title":"Biochim Biophys Acta"},{"key":"742_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4062\/biomolther.2023.156","volume":"32","author":"A Gupta","year":"2024","unstructured":"Gupta A, Haldhar R, Agarwal V et al (2024) Exploring the potential of natural products as FoxO1 inhibitors: an in Silico approach. Biomol Ther (Seoul) 32:390\u2013398. https:\/\/doi.org\/10.4062\/biomolther.2023.156","journal-title":"Biomol Ther (Seoul)"},{"key":"742_CR30","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1038\/s41598-020-74251-1","volume":"10","author":"NS Sakle","year":"2020","unstructured":"Sakle NS, More SA, Mokale SN (2020) A network pharmacology-based approach to explore potential targets of caesalpinia pulcherima: an updated prototype in drug discovery. Sci Rep 10:17217. https:\/\/doi.org\/10.1038\/s41598-020-74251-1","journal-title":"Sci Rep"},{"key":"742_CR31","doi-asserted-by":"publisher","first-page":"102247","DOI":"10.1016\/j.jbc.2022.102247","volume":"298","author":"C Arter","year":"2022","unstructured":"Arter C, Trask L, Ward S et al (2022) Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors. J Biol Chem 298:102247. https:\/\/doi.org\/10.1016\/j.jbc.2022.102247","journal-title":"J Biol Chem"},{"key":"742_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.molcel.2020.10.003","volume":"80","author":"JA Lees","year":"2020","unstructured":"Lees JA, Li PQ, Kumar N et al (2020) Insights into lysosomal PI(3,5)P2 homeostasis from a Structural-Biochemical analysis of the PIKfyve lipid kinase complex. Mol Cell 80:736\u2013743e4. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.003","journal-title":"Mol Cell"},{"key":"742_CR33","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/molecules27144391","volume":"27","author":"NA Alturki","year":"2022","unstructured":"Alturki NA, Mashraqi MM, Alzamami A et al (2022) In-Silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2. Molecules 27:4391 https:\/\/doi.org\/10.3390\/molecules27144391","journal-title":"Molecules"},{"key":"742_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2308072","author":"V Agarwal","year":"2024","unstructured":"Agarwal V, Haldhar R, Hirad AH et al (2024) Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches. J Biomol Struct Dyn https:\/\/doi.org\/10.1080\/07391102.2024.2308072","journal-title":"J Biomol Struct Dyn"},{"key":"742_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4137\/BBI.S38317","volume":"10","author":"A John","year":"2016","unstructured":"John A, Umashankar V, Samdani A et al (2016) In Silico structure prediction of human fatty acid synthase-dehydratase: a plausible model for Understanding active site interactions. Bioinform Biol Insights 10:143\u2013154. https:\/\/doi.org\/10.4137\/BBI.S38317","journal-title":"Bioinform Biol Insights"},{"key":"742_CR36","doi-asserted-by":"crossref","unstructured":"Sahu A, Pradhan D, Raza K et al (2020) In silico library design, screening and MD simulation of COX-2 inhibitors for anticancer activity. In: EPiC Series in Computing. pp 21\u201332","DOI":"10.29007\/z2wx"},{"key":"742_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-28716-8","volume":"13","author":"D Pirolli","year":"2023","unstructured":"Pirolli D, Righino B, Camponeschi C et al (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein\/ACE2 interface. Sci Rep 13:1\u201315. https:\/\/doi.org\/10.1038\/s41598-023-28716-8","journal-title":"Sci Rep"},{"key":"742_CR38","doi-asserted-by":"publisher","DOI":"10.33263\/BRIAC142.047","author":"V Agarwal","year":"2024","unstructured":"Agarwal V, Rehman M, Chaudhary R et al (2024) Exploring the potential of Natural-like compounds as TNF\u03b1 inhibitors: an In-silico approach. Biointerface Res Appl Chem https:\/\/doi.org\/10.33263\/BRIAC142.047","journal-title":"Biointerface Res Appl Chem"},{"key":"742_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-50992-7","volume":"14","author":"V Pandya","year":"2024","unstructured":"Pandya V, Rao P, Prajapati J et al (2024) Pinpointing top inhibitors for GSK3\u03b2 from pool of indirubin derivatives using rigorous computational workflow and their validation using molecular dynamics (MD) simulations. Sci Rep 14:1\u201325. https:\/\/doi.org\/10.1038\/s41598-023-50992-7","journal-title":"Sci Rep"},{"key":"742_CR40","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s11224-022-01999-9","volume":"33","author":"AO Mohammed","year":"2022","unstructured":"Mohammed AO, Abo-Idrees MI, Makki AA et al (2022) Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Struct Chem 33:1553\u20131567. https:\/\/doi.org\/10.1007\/s11224-022-01999-9","journal-title":"Struct Chem"},{"key":"742_CR41","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"742_CR42","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"742_CR43","doi-asserted-by":"publisher","first-page":"e03724","DOI":"10.1016\/j.heliyon.2020.e03724","volume":"6","author":"Y Isyaku","year":"2020","unstructured":"Isyaku Y, Uzairu A, Uba S (2020) Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents. Heliyon 6:e03724. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03724","journal-title":"Heliyon"},{"key":"742_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10819-7","author":"D Gopal","year":"2024","unstructured":"Gopal D, Muthuraj R, Balaya RDA et al (2024) Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-024-10819-7","journal-title":"Mol Divers"},{"key":"742_CR45","doi-asserted-by":"publisher","first-page":"229500","DOI":"10.1242\/jcs.229500","volume":"132","author":"C Bissig","year":"2019","unstructured":"Bissig C, Crois\u00e9 P, Heiligenstein X et al (2019) The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation. J Cell Sci 132:229500 https:\/\/doi.org\/10.1242\/jcs.229500","journal-title":"J Cell Sci"},{"key":"742_CR46","doi-asserted-by":"publisher","first-page":"32105","DOI":"10.1074\/jbc.M111.227512","volume":"286","author":"S Dupuis-Coronas","year":"2011","unstructured":"Dupuis-Coronas S, Lagarrigue F, Ramel D et al (2011) The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness. J Biol Chem 286:32105\u201332114. https:\/\/doi.org\/10.1074\/jbc.M111.227512","journal-title":"J Biol Chem"},{"key":"742_CR47","doi-asserted-by":"publisher","first-page":"17518","DOI":"10.1073\/pnas.0702275104","volume":"104","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Zolov SN, Chow CY et al (2007) Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci U S A 104:17518\u201317523. https:\/\/doi.org\/10.1073\/pnas.0702275104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"742_CR48","doi-asserted-by":"publisher","first-page":"17472","DOI":"10.1073\/pnas.1203106109","volume":"109","author":"SN Zolov","year":"2012","unstructured":"Zolov SN, Bridges D, Zhang Y et al (2012) In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc Natl Acad Sci U S A 109:17472\u201317477. https:\/\/doi.org\/10.1073\/pnas.1203106109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"742_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/embor.2012.183","volume":"14","author":"A Oppelt","year":"2013","unstructured":"Oppelt A, Lobert VH, Haglund K et al (2013) Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration. EMBO Rep 14:57\u201364. https:\/\/doi.org\/10.1038\/embor.2012.183","journal-title":"EMBO Rep"},{"key":"742_CR50","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1074\/jbc.M112.395087","volume":"288","author":"Y Mochizuki","year":"2013","unstructured":"Mochizuki Y, Ohashi R, Kawamura T et al (2013) Phosphatidylinositol 3-Phosphatase Myotubularin-related protein 6 (MTMR6) is regulated by small GTPase Rab1B in the early secretory and autophagic Pathways *. J Biol Chem 288:1009\u20131021. https:\/\/doi.org\/10.1074\/jbc.M112.395087","journal-title":"J Biol Chem"},{"key":"742_CR51","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.3892\/mmr.2025.13541","volume":"32","author":"C-X Li","year":"2025","unstructured":"Li C-X, Xu Q, Jiang S-T et al (2025) Anticancer effects of Salvianolic acid A through multiple signaling pathways (Review). Mol Med Rep 32:13541 https:\/\/doi.org\/10.3892\/mmr.2025.13541","journal-title":"Mol Med Rep"},{"key":"742_CR52","doi-asserted-by":"publisher","first-page":"113695","DOI":"10.1016\/j.intimp.2024.113695","volume":"144","author":"L Yin","year":"2025","unstructured":"Yin L, He Z, Fan Y et al (2025) Marein ameliorates the progression of osteoarthritis: an in vitro and in vivo studies. Int Immunopharmacol 144:113695. https:\/\/doi.org\/10.1016\/j.intimp.2024.113695","journal-title":"Int Immunopharmacol"},{"key":"742_CR53","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.prmcm.2022.100185","volume":"5","author":"DK Patel","year":"2022","unstructured":"Patel DK (2022) Biological importance and therapeutic potential of trilobatin in the management of human disorders and associated secondary complications. Pharmacol Res - Mod Chin Med 5:100185. https:\/\/doi.org\/10.1016\/j.prmcm.2022.100185","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"742_CR54","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.3390\/antiox10101620","volume":"10","author":"L-H Chien","year":"2021","unstructured":"Chien L-H, Wu C-T, Deng J-S et al (2021) Salvianolic acid C protects against Cisplatin-Induced acute kidney injury through Attenuation of Inflammation, oxidative stress and apoptotic effects and activation of the CaMKK\u2013AMPK\u2013Sirt1-Associated signaling pathway in mouse models. Antioxidants 10:101620 https:\/\/doi.org\/10.3390\/antiox10101620","journal-title":"Antioxidants"},{"key":"742_CR55","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1080\/10408398.2022.2065661","volume":"63","author":"D Yang","year":"2023","unstructured":"Yang D, Zhang Q-F (2023) The natural source, physicochemical properties, biological activities and metabolism of Astilbin. Crit Rev Food Sci Nutr 63:9506\u20139518. https:\/\/doi.org\/10.1080\/10408398.2022.2065661","journal-title":"Crit Rev Food Sci Nutr"},{"key":"742_CR56","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/foods9091222","volume":"9","author":"V Sritalahareuthai","year":"2020","unstructured":"Sritalahareuthai V, Temviriyanukul P, On-nom N et al (2020) Phenolic profiles, antioxidant, and inhibitory activities of Kadsura heteroclita (Roxb.) Craib and Kadsura coccinea (Lem.) A.C. Sm. Foods 9:1222 https:\/\/doi.org\/10.3390\/foods9091222","journal-title":"Foods"},{"key":"742_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2024.1411801","volume":"12","author":"F Liang","year":"2024","unstructured":"Liang F (2024) Inhibition mechanism investigation of Quercetagetin as a potential tyrosinase inhibitor. Front Chem 12:1\u20138. https:\/\/doi.org\/10.3389\/fchem.2024.1411801","journal-title":"Front Chem"},{"key":"742_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","volume":"97","author":"M Naveed","year":"2018","unstructured":"Naveed M, Hejazi V, Abbas M et al (2018) Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed Pharmacother 97:67\u201374. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.064","journal-title":"Biomed Pharmacother"},{"key":"742_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.38212\/2224-6614.3107","volume":"29","author":"NZ Msomi","year":"2021","unstructured":"Msomi NZ, Erukainure OL, Islam MS (2021) Suitability of sugar alcohols as antidiabetic supplements: a review. J Food Drug Anal 29:1\u201314. https:\/\/doi.org\/10.38212\/2224-6614.3107","journal-title":"J Food Drug Anal"},{"key":"742_CR60","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms23062914","volume":"23","author":"SCH Rehfeldt","year":"2022","unstructured":"Rehfeldt SCH, Silva J, Alves C et al (2022) Neuroprotective effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced damage in undifferentiated and RA-Differentiated SH-SY5Y cells. Int J Mol Sci 23:2914 https:\/\/doi.org\/10.3390\/ijms23062914","journal-title":"Int J Mol Sci"},{"key":"742_CR61","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3858\/emm.2010.42.7.053","volume":"42","author":"A Woo","year":"2010","unstructured":"Woo A, Min B, Ryoo S (2010) Piceatannol-3\u2019-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through Inhibition of arginase activity. Exp Mol Med 42:524\u2013532. https:\/\/doi.org\/10.3858\/emm.2010.42.7.053","journal-title":"Exp Mol Med"},{"key":"742_CR62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/insects14080671","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Xu Y, Wu S et al (2023) Validamycin inhibits the synthesis and metabolism of Trehalose and Chitin in the Oriental fruit Fly, bactrocera dorsalis (Hendel). Insects 14:671 https:\/\/doi.org\/10.3390\/insects14080671","journal-title":"Insects"},{"key":"742_CR63","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","volume":"15","author":"S Kar","year":"2020","unstructured":"Kar S, Leszczynski J (2020) Open access in Silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov 15:1473\u20131487. https:\/\/doi.org\/10.1080\/17460441.2020.1798926","journal-title":"Expert Opin Drug Discov"},{"key":"742_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7324\/JAPS.2022.120418","volume":"12","author":"KMA Azzam","year":"2022","unstructured":"Azzam KMA, Negim ES, Aboul-Enein HY (2022) ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: in Silico study. J Appl Pharm Sci 12:159\u2013169. https:\/\/doi.org\/10.7324\/JAPS.2022.120418","journal-title":"J Appl Pharm Sci"},{"key":"742_CR65","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1080\/07391102.2020.1796812","volume":"39","author":"R Yadav","year":"2021","unstructured":"Yadav R, Imran M, Dhamija P et al (2021) Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. J Biomol Struct Dyn 39:6617\u20136632. https:\/\/doi.org\/10.1080\/07391102.2020.1796812","journal-title":"J Biomol Struct Dyn"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00742-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:15:24Z","timestamp":1779797724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00742-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00742-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"30"}}